Meijer, L

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. [electronic resource] - European journal of biochemistry Jan 1997 - 527-36 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0014-2956

10.1111/j.1432-1033.1997.t01-2-00527.x doi


Adenosine Triphosphate--metabolism
Amino Acid Sequence
Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Binding Sites
CDC2 Protein Kinase--antagonists & inhibitors
CDC2-CDC28 Kinases
Calcium-Calmodulin-Dependent Protein Kinases--metabolism
Cell Cycle--drug effects
Cyclin-Dependent Kinase 2
Cyclin-Dependent Kinase 5
Cyclin-Dependent Kinases--antagonists & inhibitors
Enzyme Inhibitors--pharmacology
Growth Inhibitors--pharmacology
Humans
Kinetin
Leukemia L1210--enzymology
Maturation-Promoting Factor--metabolism
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Molecular Sequence Data
Oogenesis
Phosphorylation--drug effects
Phosphotyrosine--metabolism
Protein Kinase Inhibitors
Protein Serine-Threonine Kinases--antagonists & inhibitors
Purines--pharmacology
Roscovitine
Sea Urchins
Starfish
Substrate Specificity
Vimentin--metabolism
Xenopus Proteins
Xenopus laevis